Clinical trials: Photobiomodulation
Dry Age-related Macular Degeneration
Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III)
This LIGHTSITE III study is a double-masked, sham-controlled, parallel design, prospective multi-site study for the use of PBM as a treatment for visual impairment in subjects with dry AMD.
- Trial name
- NCT04065490
- Testing
- Valeda Light Delivery System
- Where
- 10 sites in United States
- Volunteers
- 100 people
- Sponsor
- LumiThera, Inc.
Pressure Ulcer (PU)
The Effect of Photobiomodulation on Pressure Ulcers
Photobiomodulation Group (Intervention Group): Before the intervention, the patient's skin sensitivity to light will be tested by applying light for 3 minutes to one-fourth of the forearm skin.
- Trial name
- Pressure Ulcer (NCT07307885)
- Testing
- photobiomodulation
- Where
- Turkey (Türkiye)
- Volunteers
- 46 people, healthy volunteers welcome
- Sponsor
- Ankara Medipol University
Osteoarthritis Of Knee
Evaluating the Effectiveness of Using a Home Laser Device to Treat Patients With Knee Osteoarthritis
Osteoarthritis is a degenerative disease affecting joint cartilage and its surrounding tissue. It is the leading cause of disability in the elderly.
- Trial name
- NCT06773676
- Testing
- B-Cure laser pro
- Where
- Israel
- Volunteers
- 50 people
- Sponsor
- Barzilai Medical Center
Melasma
Treatment of Melasma With Yellow Light Compared to Tranexamic Acid
Photobiomodulation (PBM) has been suggested as an alternative treatment for Melasma, showed by the in vitro data, inhibition of the tyrosinase enzyme and reduction in the pigment content by autophagy.
- Trial name
- NCT05326997
- Testing
- Photobiomodulation group, Group control (Tranexamic acid)
- Where
- 2 sites in Brazil
- Volunteers
- 21 people
- Sponsor
- University of Nove de Julho